Weight loss in patients with hematological neoplasias is associated with immune system stimulation (original) (raw)

References

  1. Balkwill F, Burke F, Talbot D, Taverniere J, Osborne R, Naylor S, Durbin H, Fiers W (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 11:1229–1232
    Google Scholar
  2. Bonadonna G, Santoro A, Viviani S, Valagussa P (1988) Treatment strategies for Hodgkin's disease. Sem Hematol 25:51–57
    Google Scholar
  3. Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM (1989) Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2. Cancer Res 49:4941–4944
    Google Scholar
  4. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report on the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860–1861
    CAS PubMed Google Scholar
  5. Denz HA, Fuchs D, Grünewald K, Huber H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H (1990) Urinary neopterin as a prognostic factor in haematological neoplasias. Pteridines 1:167–170
    Google Scholar
  6. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H (1990) Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 44:186–189
    Google Scholar
  7. Denz H, Landmann R, Orth B, Wachter H, Fuchs D (1992) Associations between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur J Haematol 48:245–249
    Google Scholar
  8. DeWyss WD, Begg C, Lavin PT, Band PR, Bennet JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight-loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–501
    Google Scholar
  9. Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842–854
    CAS PubMed Google Scholar
  10. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H (1988) Neopterin as a marker for activated cell-mediated immunity — application in HIV infection. Immunol Today 9:150–155
    Google Scholar
  11. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner E, Wachter H (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J AIDS 3:873–876
    Google Scholar
  12. Fuchs D, Dotevall L, Hagberg L, Werner ER, Wachter H (1991) Kynurenine in cerebrospinal fluid of patients with Lyme neuroborreliosis. Immunol Infect Dis 1:271–274
    Google Scholar
  13. Herrmann F, Cannistra SA, Griffin JD (1986) T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro. J Immunol 136:2856–2861
    Google Scholar
  14. Klein B, Zhang XG, Jourdan M, Content J, Houssian F, Aarden L, Piechaczyk M, Bataille R (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73: 517–526
    Google Scholar
  15. Matthys P, Dukmans R, Proost P, Van Damme J, Heremans H, Sobis H, Billiau A (1991) Severe cachexia in mice inoculated with interferon-gamma producing tumor cells. Int J Cancer 49:77–82
    Google Scholar
  16. Metcalf D (1989) Haematopoietic growth factors 1. Lancet 1:825–827
    Google Scholar
  17. Moldawer LL, Andersson C, Gelin J, Lundholm KG (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:450–456
    Google Scholar
  18. Morrison SD (1989) Cancer cachexia. In: Liotta LA (ed) Influence of tumor development on the host. Series Kaiser HE: Cancer growth and progression (3). Kluwer Academic Publishers, Dordrecht, pp 176–213
    Google Scholar
  19. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry S (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167:1211–1227
    Google Scholar
  20. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER (1989) Neopterin as marker of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27:81–141
    Google Scholar
  21. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G (1992) Neopterin: biochemistry-methods-clinical Application. de Gruyter, Berlin
    Google Scholar
  22. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H (1987) Human macrophages degrade tryptophan upon induction by interferon gamma. Life Sci 41:273–280
    Google Scholar
  23. Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1987) Simultaneous determination of neopterin and creatinine in serum with solid phase extraction and on-line elution liquid chromatography. Clin Chem 33:2028–2033
    Google Scholar
  24. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1989) Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 370:1063–1069
    Google Scholar
  25. Wright SC, Jewett A, Misuyasu R, Bonavida B (1988) Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 141:99–104
    Google Scholar

Download references